Loading clinical trials...

A Nutritional Approach to Minimal Hepatic Encephalopathy | Clinical Trials | Clareo Health

UNKNOWNNA

A Nutritional Approach to Minimal Hepatic Encephalopathy

NCT01083446•Tel-Aviv Sourasky Medical Center

Summary

This trial will study a possible effect of standard Israeli breakfast (30% of caloric value and 21 gram protein) on cognitive and executive functions (working memory, visual memory, concentration and coordination), on patients with mild-moderate liver cirrhosis.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All consented adults (age \> 18), with the diagnosis of CHILD A cirrhosis with MELD score of \< 10.
•Diagnosis of liver cirrhosis as documented by liver biopsy (stage IV) and / or fibroscan (score \> 12 kpa) and / or fibrotest (score \> 0.74) and /or imaging.

Exclusion Criteria

•History of \> grade II hepatic encephalopathy (HE).
•Diagnosis of dementia, Parkinson disease, Schizophrenia (Patients with major depression will be noted but not excluded).
•Use of sedatives, tranquilizers or anti- psychotic medication during and/or 2 weeks prior to enrolling Use of antibiotics for any length of period during and/or 2 weeks prior to enrolling.
•Current use of lactulose or neomycin.
•Use of alcohol or elicit drugs during and/ or 6 months prior to enrolling.

Locations (1)

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel, Israel

Key Dates

Start Date

July 1, 2008

Primary Completion Date

July 1, 2010

Completion Date

August 1, 2010

Last Updated

March 9, 2010

Enrollment

ESTIMATED participants

Conditions

Minimal Hepatic Encephalopathy

Interventions

Nutritional Intervention

OTHER

Nutritional Intervention

OTHER

Contacts

Nachum Vaisman, Prof'

CONTACT

+972-3-6974807 vaisman@tasmc.health.gov.il

Psychometric Hepatic Encephalopathy Score in Prediction of Minimal Hepatic Encephalopathy in Compensated Cirrhotic Patients

NCT07272707

Minimal Hepatic Encephalopathy

View study

COMPLETEDPHASE2

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)

NCT03585257

CirrhosisHepatic Encephalopathy+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2010Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions